stockportfolio.pro
Stocks / ALHC vs ERAS
ALHC vs ERAS
Alignment Healthcare, Inc. and Erasca, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Alignment Healthcare, Inc. (ALHC) | Erasca, Inc. (ERAS) | |
|---|---|---|
| Market cap | $4.3B | $4.2B |
| Revenue (latest FY) | $3.95B | $0 |
| Net income (latest FY) | $-724,000 | $-124.55M |
| Revenue growth (5y CAGR) | 32.7% | — |
| Net margin | -0.0% | — |
| Return on equity | -0.4% | -38.3% |
| P/E ratio | 205.7 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ALHC — free Open ERAS — freeFrequently asked questions
Which is bigger, ALHC or ERAS?
Alignment Healthcare, Inc. is larger by market capitalization — $4.3B versus $4.2B.
Which grows faster, ALHC or ERAS?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.